methylene blue/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on blood haemoglobin concentration
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull result“There were no differences between CQ and CQ-MB study groups in haemoglobin and haematocrit values over time in both the G6PD deficient and sufficient subgroups (Table 3).”
Quoted verbatim from Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841].. - Study
- RCT
- Duration
- 14 days
- Dose
- 0.5% MB solution 4 mg/kg/day for three days, plus chloroquine 25 mg/kg over three days
- Population
- children aged 6-59 months with uncomplicated falciparum malaria, Burkina Faso; chloroquine given to both arms; result stated for G6PD deficient and G6PD sufficient subgroups
Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841].2005PMID:16179085Permalink
Keep reading
- Everything the graph holds on methylene blue
- Every compound studied against Blood haemoglobin concentration
- How to read the evidence strength and the marks
To cite this finding: https://catalystproject.ai/e/01M4PPX19H0XX6FYN80MR4ATJW